SURFACE OPHTHALMICS, INC.

Profile

Company Names

SURFACE OPHTHALMICS, INC.
SURFACE PHARMACEUTICALS, INC.

Addresses

5000 HOPYARD ROAD, SUITE 402, PLEASANTON, CA 94588

12264 EL CAMINO REAL, SUITE 350, SAN DIEGO, CA 92130

Phone Numbers

858-405-4448

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$40,129,838.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-05-28 
$25,129,840.00 
$30,578,103.00 
$5,448,263.00 
Equity 
1
2018-05-11 
$14,999,998.00 
$19,999,999.00 
$5,000,001.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
BAUM 
EXECUTIVE OFFICER, DIRECTOR
IMPRIMIS PHARMACEUTICALS, INC.   |  ETON PHARMACEUTICALS, INC.   |  SURFACE PHARMACEUTICALS, INC.   |  MELT PHARMACEUTICALS, INC.   |  SURFACE OPHTHALMICS, INC.
J. 
ANDREW 
CORLEY 
DIRECTOR
SURFACE PHARMACEUTICALS, INC.
J. 
ANDY 
CORLEY 
DIRECTOR
STROMA MEDICAL CORP   |  EYEBRAIN MEDICAL, INC.   |  RXSIGHT, INC.   |  EQUINOX, INC.   |  SURFACE OPHTHALMICS, INC.
LOUIS 
 
DRAPEAU 
DIRECTOR
BIONOVO INC   |  INSITE VISION INC   |  AMPLIPHI BIOSCIENCES CORP   |  SURFACE PHARMACEUTICALS, INC.
ADRIENNE 
 
GRAVES 
DIRECTOR
OCCULOGIX, INC.   |  AERPIO THERAPEUTICS, INC.   |  ENCORE VISION, INC.   |  TEARLAB CORP   |  ENVISIA THERAPEUTICS, INC.   |  SURFACE PHARMACEUTICALS, INC.   |  GREENBROOK TMS INC.   |  THEROPTIX, INC.   |  SURFACE OPHTHALMICS, INC.   |  OPUS GENETICS INC.   |  JELLISEE OPHTHALMICS INC.   |  QLARIS BIO, INC.
KAMRAN 
 
HOSSEINI 
EXECUTIVE OFFICER, DIRECTOR
INSITE VISION INC   |  SURFACE PHARMACEUTICALS, INC.   |  SURFACE OPHTHALMICS, INC.
RICHARD 
 
LINDSTROM 
DIRECTOR
VERTICAL HEALTH SOLUTIONS INC   |  OCULAR THERAPEUTIX, INC   |  FORSIGHT VISION6, INC.   |  ENCORE VISION, INC.   |  ALPHAEON CORP   |  TEARLAB CORP   |  POGOTEC, INC.   |  IMPRIMIS PHARMACEUTICALS, INC.   |  SIGHTLIFE SURGICAL, INC.   |  UNITED VISION PARTNERS HOLDINGS, LLC   |  EQUINOX, INC.   |  IANTECH, INC.   |  CORNEAGEN INC.   |  EQUINOX OPHTHALMIC, INC.   |  THEROPTIX, INC.   |  LENTECHS LLC   |  SURFACE OPHTHALMICS, INC.   |  SYDNEXIS, INC.   |  CG HOLDING CO.   |  IOR HOLDINGS, INC.   |  VINCI PHARMACEUTICALS, INC.
RICHARD 
L. 
LINDSTROM 
DIRECTOR
TEARLAB CORP   |  ELENZA, INC   |  IMPRIMIS PHARMACEUTICALS, INC.   |  SURFACE PHARMACEUTICALS, INC.   |  OCULAR THERAPEUTIX, INC   |  LENSAR, INC.   |  EYEMACULAR REGENERATION, INC.
PERRY 
 
STERNBERG 
EXECUTIVE OFFICER, DIRECTOR
SURFACE OPHTHALMICS, INC.   |  SYDNEXIS, INC.
SHELLEY 
 
THUNEN 
DIRECTOR
LENSX LASERS INC   |  RESTORATION ROBOTICS INC   |  RXSIGHT, INC.   |  SURFACE OPHTHALMICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-08-13
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-28 
2021-07-12
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-28 
2021-06-10
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-05-28 
2018-05-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NEWBRIDGE SECURITIES CORPORATION
104065
NEWBRIDGE SECURITIES CORPORATION
104065